Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Philips launches world’s first detector-based spectral CT scanner in Canada

Royal Philips
Posted on: 14 Nov 16

Royal Philips (NYSE:PHG, AEX:PHIA), a leading health technology company, today announced the launch of the Philips IQon Spectral CT in Canada. The Philips IQon Spectral CT is the world’s first and only spectral detector CT, designed specifically for spectral imaging. It delivers on-demand colour quantification and the ability to characterize structures simply and at a low dose.

The Philips IQon Spectral CT provides multiple layers of retrospective, diagnostic data in a single, low-dose scan with seamless integration into existing hospital system protocols. It can provide sufficient information with only one scan to help clinicians make fast, confident diagnoses, driving improved clinical and economic outcomes.

The IQon Spectral CT adds spectral resolution to traditional CT scanning through a new dual-layer spectral detector. It identifies photons of high energy and low energy simultaneously, allowing not only the view of anatomy, but also uses colour to characterize the material content of critical structures.

“The Philips IQon Spectral CT is further proof of our commitment of delivering meaningful innovation,” said Iain Burns, President and CEO, Philips Canada. “Today’s patient centered healthcare environment requires the ability to enable ‘first-time’ right testing and diagnostics. With just one scan, the new Philips IQon Spectral CT can provide clinicians with the information required to help them make confident diagnoses quickly.’’

The Philips IQon Spectral CT was recently used to scan the tail of Trix, a T-Rex dinosaur who was discovered in Montana, USA in 2013 and was purchased by the Naturalis museum and transported to the Netherlands in August 23, 2016. Click here to learn more.

Philips IQon Spectral CT and the full suite of Philips advanced imaging solutions will be showcased at the 2016 Radiological Society of North America Annual Meeting (RSNA), beginning November 27 through December 1 at McCormick Place in Chicago. For more information on Philips’ presence at the 2016 RSNA Annual Meeting, visit www.philips.com/rsna and follow @PhilipsLiveFrom for #RSNA16 updates throughout the event.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161114005940/en/

Business Wire
www.businesswire.com

Last updated on: 14/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.